{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 411440631
| IUPAC_name = (5α)-6,17-Dimethyl-6,7-didehydro-4,5-epoxymorphinan-3-ol
| image = Methyldesorphine.svg
| width = 180

<!--Clinical data-->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  S9
| legal_CA = Schedule I
| legal_UK =  
| legal_US = Schedule I
| legal_DE = Anlage I
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 16008-36-9
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 5362518
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = Y460N7W76B
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4515065

<!--Chemical data-->
| C=18 | H=21 | N=1 | O=2 
| molecular_weight = 283.36 g/mol
| smiles = CC1=CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C18H21NO2/c1-10-3-5-12-13-9-11-4-6-14(20)16-15(11)18(12,17(10)21-16)7-8-19(13)2/h3-4,6,12-13,17,20H,5,7-9H2,1-2H3/t12-,13+,17-,18-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = CUFWYVOFDYVCPM-GGNLRSJOSA-N
| synonyms = <small>3-Hydroxy-6,''N''-dimethyl- 4,5-epoxymorphin-6-en</small>
}}

'''Methyldesorphine''' is an [[opioid]] analgesic. First synthesized in Germany in 1940 and patented in the USA in 1952,<ref>{{cite patent | country = US | number = 2694068 | status = patent | title = Δ6-DESOXYMORPHINE COMPOUNDS AND PROCESS OF PRODUCING THE SAME | pubdate = 1952-08-05 | gdate = 1954-09-11 | inventor = Payne, G. B. ''et al.''
}}</ref> it has a high potential for abuse as with any potent opioid agonist, and is sometimes found along with [[desomorphine]] as a component of the home-made opioid mixture known as "Krokodil" used in Russia and the neighboring former Soviet republics.<ref>{{Cite journal | last1 = Savchuk   | first1 = S. A. | last2 = Barsegyan | first2 = S. S.| last3 = Barsegyan | first3 = I. B.| last4 = Kolesov   | first4 = G. M. | title = Chromatographic Study of Expert and Biological Samples Containing Desomorphine | doi = 10.1007/s10809-008-4009-5 | journal = Journal of Analytical Chemistry | volume = 63 | issue = 4 | pages = 361–370| year = 2008 | pmid =  | pmc = }}</ref> It is approximately 15 times more potent than morphine as an analgesic<ref>{{ cite book |author1=Casy, A. F. |author2=Parfitt, R. Y. | title = Opioid Analgesics, Chemistry and Receptors | year = 1986 | publisher = Plenum Press | location = New York | pages = 37–38 | isbn = 0-306-42130-5 }}</ref><ref>{{ cite book |author1=Lenz, G. R. |author2=Evans, S. M. |author3=Walters, D. E. |author4=Hopfinger, A. J. | title = Opiates | year = 1986 | page = 63 | publisher = Academic Press | isbn = 978-0-12-443830-9 }}</ref> but if the 6-7 bond is saturated, the β isomer is some 50 times more potent than morphine.

Methyldesorphine is listed as a Schedule I Narcotic controlled substance under the Controlled Substances Act 1970 in the United States with a DEA ACSCN of 9302 and zero annual aggregate manufacturing quota.  The free base conversion ratio of the hydrochloride is 0.89.<ref>http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html</ref>

==See also==
* [[6-Methylenedihydrodesoxymorphine]]

==References==
{{Reflist|2}}

{{Opioidergics}}

[[Category:Opioids]]
[[Category:Morphinans]]
[[Category:Phenols]]
[[Category:Ethers]]
[[Category:Mu-opioid agonists]]
[[Category:Semisynthetic opioids]]


{{analgesic-stub}}